Therefore, COSCs can ameliorate leptin resistance via upregulating LepRb and activating the JAK2-STAT3 signaling pathway, contributing to the improvement of obesity. The gene discussed is STAT3; the disease is obesity due to melanocortin 4 receptor deficiency.